Medicure Inc.
Medicure Inc. (MPH.V) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mph.v · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Medicure Inc. (MPH.V) measures how much investors pay for each dollar of the company's trailing earnings. MPH.V's current PE ratio of N/A is calculated by dividing its stock price of $1.04 by its TTM earnings per share of -$0.65.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2007 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%7.6x
MedianQ3 · 75%34.3x
Max
At N/A, MPH.V's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Medicure Inc.You MPH.V | $11M | N/A | — | -$0.65 |
 Blueberries Medical Corp. BBM.CN | $5M | N/A | — | -$0.00 |
 Comprehensive Healthcare Systems, Inc. CHS.V | $10M | N/A | — | -$0.15 |
 Christina Lake Cannabis Corp. CLC.CN | $7M | 7.30x | — | $0.00 |
 Crescita Therapeutics Inc. CTX.TO | $15M | N/A | — | -$0.00 |
 Delivra Health Brands Inc. DHB.V | $4M | N/A | — | -$0.04 |
 Lobe Sciences Ltd. LOBE.CN | $22M | N/A | — | -$0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.68 | — | |
2024-12-31 FY2024 | — | $-0.10 | — | |
2023-12-31 FY2023 | — | $-0.09 | — | |
2022-12-31 FY2022 | 7.59x | $0.13 | — | |
2021-12-31 FY2021 | — | $-0.07 | — | |
2020-12-31 FY2020 | — | $-0.64 | — | |
2019-12-31 FY2019 | — | $-1.32 | — | |
2018-12-31 FY2018 | 24.74x | $0.25 | +847.5% | |
2017-12-31 FY2017 | 2.61x | $2.78 | -53.3% | |
2016-12-31 FY2016 | 5.59x | $1.84 | -83.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Medicure Inc. (MPH.V) measures how much investors pay for each dollar of the company's trailing earnings. MPH.V's current PE ratio of N/A is calculated by dividing its stock price of $1.04 by its TTM earnings per share of -$0.65.
Frequently asked questions
MPH.V pe ratio · 6 questionsMPH.V's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.04 and TTM EPS of -$0.65. Data sourced from Financial Modeling Prep via MPH.V's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medicure Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09